Resultados de la búsqueda 161-170 of 1803 for GLP-1 secretion
Patients will be randomized 1:1 into the two arms. Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will ...
... release. International Hepatobiliary Neoplasia ... 1. Create a registry of patients having or at ... one month. A Vaccine (H2NVAC) Before Surgery for ...
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
A separate Phase 1 cohort will assess the combination of JCAR017 and concurrent ibrutinib. ... release. International Penile Advanced Cancer ... Patients may be ...
Un nivel de glucosa en la sangre de 200 mg/dl (11,1 mmol/l) o superior sugiere la presencia de diabetes. ... Los agonistas del receptor GLP-1 son medicamentos que ...
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
... release. A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma ... Ir a página 11 · Ir a página 22 ...
... release. International Hepatobiliary Neoplasia ... 1. Create a registry of patients having or at ... Patients will receive VSL#3® 450B sachets probiotics, which ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
A separate Phase 1 cohort will assess the combination of JCAR017 and concurrent ibrutinib. ... Patients may be allocated to one ... release. Numeración de páginas ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?